RIVN
Rivian Automotive, Inc.
RIVN offers stronger valuation, but that advantage does not outweigh its weaker overall profile.
SBH
Sally Beauty Holdings, Inc.
SBH has a slight edge over RIVN overall, supported by lower modeled downside.
RIVN Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Weak | |
| Weak | |
| Unavailable |
RIVN's revenue is currently healthy, but its profitability and cash flow are weak. There isn't enough data to rate its balance sheet.
SBH Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Healthy | |
| Healthy | |
| Healthy |
SBH's profitability, cash flow and balance sheet are currently healthy, and its revenue is stable.
RIVN PE Valuation
RIVN has no meaningful PE right now: it lost money over the past year.
SBH PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 6.1x | $12.33 | -33% |
| Fair | 7.9x | $15.93 | -13% |
| Forward | 8.2x | $18.41 | — |
| Current | 9.1x | $18.41 | — |
| Expensive | 9.8x | $19.70 | +7% |
Historical ranges are pointers, not guarantees.
SBH's PE is in its expensive range at 9.1x. If earnings grow as analysts expect, today's price would be 8.2x next year's earnings, in its fair range.
RIVN Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Strong growth | |
| Strongly improving | |
| Limited | |
| Low |
RIVN has the edge over SBH on the outlook, with more favorable revenue expectations.
SBH Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Growth | |
| Stable | |
| Improving | |
| Limited | |
| High |
Analysts expect SBH's earnings to grow and its profitability to improve, with its revenue holding steady.
RIVN Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$2.25 | +$0.83 |
| Q2 2026 | -$2.58 | +$0.62 |
| Q1 2026 | -$2.92 | +$0.77 |
| Q4 2025 | -$3.07 | +$1.62 |
| Q3 2025 | -$3.08 | +$2.52 |
| Q2 2025 | -$3.20 | +$2.76 |
| Q1 2025 | -$3.69 | +$2.08 |
| Q4 2024 | -$4.69 | +$1.05 |
RIVN is still losing money, but far less than before: $2.25 per share over the past year, against $7.40 at its worst in late 2022.
SBH Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $2.26 | +12% |
| Q3 2026 | $2.02 | +6.9% |
| Q2 2026 | $1.92 | +3.8% |
| Q1 2026 | $1.81 | +2.3% |
| Q4 2025 | $1.76 | +6% |
| Q3 2025 | $1.89 | +32% |
| Q2 2025 | $1.85 | +34% |
| Q1 2025 | $1.77 | +20% |
| Q4 2024 | $1.66 | +5.1% |
SBH has the edge over RIVN on earnings quality, reporting a profit while its opponent remains loss making.
RIVN Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $2.2B | +38% |
| Q2 2026 | $1.7B | +27% |
| Q1 2026 | $1.4B | +11% |
| Q4 2025 | $1.3B | -26% |
| Q3 2025 | $1.6B | +78% |
| Q2 2025 | $1.3B | +13% |
| Q1 2025 | $1.2B | +3% |
| Q4 2024 | $1.7B | +32% |
RIVN has the edge over SBH on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -41% | +22 points |
| Q2 2026 | -50% | +35 points |
| Q1 2026 | -64% | -11 points |
| Q4 2025 | -65% | -27 points |
| Q3 2025 | -63% | +71 points |
| Q2 2025 | -86% | +33 points |
| Q1 2025 | -53% | +70 points |
| Q4 2024 | -38% | +82 points |
RIVN's operating margin was −41% last quarter, up 22 points from the same quarter a year ago, near the top of its range since 2021.
SBH Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $952.5M | +0.6% |
| Q2 2026 | $935.5M | +0.2% |
| Q1 2026 | $903.4M | +2.3% |
| Q4 2025 | $943.2M | +0.6% |
| Q3 2025 | $947.1M | +1.3% |
| Q2 2025 | $933.3M | -1% |
| Q1 2025 | $883.1M | -2.8% |
| Q4 2024 | $937.9M | +0.7% |
SBH's revenue has held roughly level: $953M last quarter, about level with the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 9.7% | +1.2 points |
| Q2 2026 | 9.2% | +0.9 points |
| Q1 2026 | 8% | +0.1 points |
| Q4 2025 | 8.1% | -2.6 points |
| Q3 2025 | 8.4% | -0.4 points |
| Q2 2025 | 8.4% | +0.8 points |
| Q1 2025 | 7.9% | +1.3 points |
| Q4 2024 | 11% | +3.3 points |
SBH has the edge over RIVN on profitability, with a higher operating margin.
RIVN Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$1.1B | -$703M |
| Q2 2026 | -$849M | -$451M |
| Q1 2026 | -$1.1B | -$549M |
| Q4 2025 | -$1.1B | -234% |
| Q3 2025 | -$421M | +$732M |
| Q2 2025 | -$398M | +$639M |
| Q1 2025 | -$526M | +$997M |
| Q4 2024 | $856M | +$2.3B |
RIVN has burned cash in almost every quarter: −$4.2B over the past year, against −$489M the year before.
SBH Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $46.9M | -40% |
| Q2 2026 | $61.6M | +25% |
| Q1 2026 | $44.1M | +37% |
| Q4 2025 | $57.5M | +329% |
| Q3 2025 | $78M | +6.4% |
| Q2 2025 | $49.1M | +71% |
| Q1 2025 | $32.2M | +41% |
| Q4 2024 | $13.4M | -35% |
SBH has the edge over RIVN on cash generation, producing positive trailing cash flow while its opponent burns cash.
RIVN Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +9.1% | +121M shares |
| 1 year | +19% | +226M shares |
| 3 years | +52% | +494M shares |
RIVN has 1.4B diluted shares, up 19% from a year ago.
| Quarter | Spent |
|---|---|
| Q2 2021 | — |
| Q1 2021 | — |
| Q4 2020 | $6M |
| Q3 2020 | — |
| Q2 2020 | — |
| Q1 2020 | — |
SBH Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.9% | +902K shares |
| 1 year | -4.8% | -5M shares |
| 3 years | -9.6% | -10.5M shares |
| 5 years | -13% | -15.4M shares |
| Available history | -16% | -18.3M shares |
SBH has the edge over RIVN on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $41.9M |
| Q2 2026 | $25.6M |
| Q1 2026 | $25.6M |
| Q4 2025 | $20.8M |
| Q3 2025 | $20.7M |
| Q2 2025 | $13.2M |
| Q1 2025 | $10.2M |
| Q4 2024 | $9.9M |
SBH spent $114M buying back its own shares over the past year, up 111% from the year before.
RIVN Net Leverage
RIVN's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
SBH Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 1.5x | Healthy |
| Q2 2026 | 1.5x | Healthy |
| Q1 2026 | 1.7x | Healthy |
| Q4 2025 | 1.7x | Healthy |
| Q3 2025 | 1.7x | Healthy |
| Q2 2025 | 1.8x | Healthy |
| Q1 2025 | 1.9x | Healthy |
| Q4 2024 | 2.0x | Healthy |
SBH's net debt is about 1.5 years of its operating earnings (EBITDA), down from 1.7 years a year ago.
RIVN Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 41.5 | Neutral |
| Stochastic | 25.6 | Neutral |
RIVN's weekly RSI is 41 (neutral) and its Stochastic is 26 (neutral).
SBH Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 65.5 | Neutral |
| Stochastic | 72.0 | Neutral |
SBH's weekly RSI is 65 (neutral) and its Stochastic is 72 (neutral).
RIVN PE vs Consumer Cyclical Sector
RIVN has no meaningful PE right now: it lost money over the past year.
SBH PE vs Consumer Cyclical Sector
| Metric | SBH | Sector median | Relative |
|---|---|---|---|
| PE | 9.1x | 18x | 49% below |
| PE % | 76 | 47 | 29 pts above |
SBH is trading at 9.1x earnings, a 49% discount to the Consumer Cyclical sector's median of 18x.
RIVN Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $13.3 | 3.9% below |
| 20 week MA | $15.1 | 15% below |
| 50 week MA | $15.9 | 19% below |
| 100 week MA | $14.7 | 13% below |
| 200 week MA | $15.1 | 15% below |
RIVN is in a downtrend: it's below all five of its weekly moving averages, and 15% below its 200-week average.
SBH Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $17.3 | 6.5% above |
| 20 week MA | $16.4 | 13% above |
| 50 week MA | $15.2 | 21% above |
| 100 week MA | $13.2 | 39% above |
| 200 week MA | $12.6 | 46% above |
SBH has the edge over RIVN on trend strength, trading above more of its moving averages.
RIVN Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2021 | $130.0 | $96.8 | -25% |
| 2022 | $96.8 | $19.1 | -80% |
| 2023 | $19.1 | $23.5 | +23% |
| 2024 | $23.5 | $13.7 | -42% |
| 2025 | $13.7 | $20.9 | +53% |
| 2026 YTD | $20.9 | $12.8 | -39% |
RIVN has finished lower in three of the last five years. It's down 39% so far in 2026.
SBH Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $18.1 | $12.7 | -30% |
| 2021 | $12.7 | $18.6 | +47% |
| 2022 | $18.6 | $12.5 | -33% |
| 2023 | $12.5 | $13.3 | +6.4% |
| 2024 | $13.3 | $10.8 | -18% |
| 2025 | $10.8 | $15.0 | +38% |
| 2026 YTD | $15.0 | $18.4 | +23% |
SBH has the edge over RIVN on returns for 2026, with the stronger performance.